HEADER TRANSFERASE 16-MAR-04 1UZU TITLE GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH INDIRUBIN-5'-SULPHONATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1; COMPND 6 OTHER_DETAILS: INDIRUBIN-5'-SULPHONATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS TRANSFERASE, GLYCOSYLTRANSFERASE, GLYCOGEN METABOLISM, CARBOHYDRATE KEYWDS 2 METABOLISM, PYRIDOXAL PHOSPHATE EXPDTA X-RAY DIFFRACTION AUTHOR M.N.KOSMOPOULOU,D.D.LEONIDAS,E.D.CHRYSINA,N.BISCHLER,G.EISENBRAND, AUTHOR 2 C.E.SAKARELLOS,R.PAUPTIT,N.G.OIKONOMAKOS REVDAT 4 13-DEC-23 1UZU 1 REMARK LINK REVDAT 3 06-FEB-19 1UZU 1 JRNL REMARK REVDAT 2 24-FEB-09 1UZU 1 VERSN REVDAT 1 27-MAY-04 1UZU 0 JRNL AUTH M.N.KOSMOPOULOU,D.D.LEONIDAS,E.D.CHRYSINA,N.BISCHLER, JRNL AUTH 2 G.EISENBRAND,C.E.SAKARELLOS,R.PAUPTIT,N.G.OIKONOMAKOS JRNL TITL BINDING OF THE POTENTIAL ANTITUMOUR AGENT JRNL TITL 2 INDIRUBIN-5-SULPHONATE AT THE INHIBITOR SITE OF RABBIT JRNL TITL 3 MUSCLE GLYCOGEN PHOSPHORYLASE B. COMPARISON WITH LIGAND JRNL TITL 4 BINDING TO PCDK2-CYCLIN A COMPLEX. JRNL REF EUR. J. BIOCHEM. V. 271 2280 2004 JRNL REFN ISSN 0014-2956 JRNL PMID 15153119 JRNL DOI 10.1111/J.1432-1033.2004.04173.X REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3076180.310 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 41950 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2099 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5131 REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 294 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6581 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 283 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.76000 REMARK 3 B22 (A**2) : 3.76000 REMARK 3 B33 (A**2) : -7.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.210 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.370 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 50.46 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PLP.PARAM REMARK 3 PARAMETER FILE 3 : CWATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NW1.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : PLP.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NW1.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UZU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-04. REMARK 100 THE DEPOSITION ID IS D_1290014812. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 6.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1GFZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BES, EDTA, PH 6.7, SMALL TUBES, REMARK 280 TEMPERATURE 289K, PH 6.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.19450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.32600 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.32600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.29175 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.32600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.32600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.09725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.32600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.32600 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.29175 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.32600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.32600 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.09725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.19450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.38900 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2267 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 PHOSPHORYLASE IS AN IMPORTANT ALLOSTERIC ENZYME IN REMARK 400 CARBOHYDRATE METABOLISM. ENZYMES FROM DIFFERENT SOURCES REMARK 400 DIFFER IN THEIR REGULATORY MECHANISMS AND IN THEIR REMARK 400 NATURAL SUBSTRATES. HOWEVER, ALL KNOWN PHOSPHORYLASES REMARK 400 SHARE CATALYTIC AND STRUCTURAL PROPERTIES. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 ASP A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ARG A 10 REMARK 465 LYS A 11 REMARK 465 ASN A 253 REMARK 465 LEU A 254 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 838 CA C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 15 -7.97 -56.99 REMARK 500 ALA A 19 70.40 -110.98 REMARK 500 LEU A 131 45.19 -86.57 REMARK 500 TYR A 203 -131.44 65.11 REMARK 500 GLN A 211 79.86 -114.17 REMARK 500 ARG A 234 29.87 48.19 REMARK 500 LEU A 271 -32.92 -142.70 REMARK 500 PRO A 281 31.13 -83.62 REMARK 500 PHE A 326 12.23 -69.64 REMARK 500 ASP A 339 -168.39 79.00 REMARK 500 THR A 466 -89.54 -134.23 REMARK 500 LYS A 482 89.77 -150.14 REMARK 500 LEU A 492 -70.73 -147.49 REMARK 500 ASP A 514 63.58 -165.88 REMARK 500 TYR A 553 -3.12 88.43 REMARK 500 LYS A 554 78.17 35.64 REMARK 500 VAL A 555 -163.62 -107.87 REMARK 500 HIS A 556 38.38 -148.26 REMARK 500 LYS A 568 170.65 177.23 REMARK 500 SER A 674 -63.87 -147.78 REMARK 500 LYS A 772 65.74 34.17 REMARK 500 ASN A 793 78.79 -117.91 REMARK 500 PRO A 835 74.03 -46.72 REMARK 500 ALA A 836 173.90 40.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INR A1000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A8I RELATED DB: PDB REMARK 900 SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE REMARK 900 RELATED ID: 1ABB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE COMPLEX WITH PYRIDOXAL- 5'-DIPHOSPHATE REMARK 900 RELATED ID: 1AXR RELATED DB: PDB REMARK 900 COOPERATIVITY BETWEEN HYDROGEN-BONDING AND CHARGE-DIPOLE REMARK 900 INTERACTIONS IN THE INHIBITION OF BETA-GLYCOSIDASES BY REMARK 900 AZOLOPYRIDINES: EVIDENCE FROM A STUDY WITH GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1B4D RELATED DB: PDB REMARK 900 AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE REMARK 900 RELATED ID: 1BX3 RELATED DB: PDB REMARK 900 EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN PHOSPHORYLASE REMARK 900 ACTIVITY AND STRUCTURE REMARK 900 RELATED ID: 1C50 RELATED DB: PDB REMARK 900 IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL REMARK 900 ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1C8K RELATED DB: PDB REMARK 900 FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1C8L RELATED DB: PDB REMARK 900 SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG AND CAFFEINE REMARK 900 RELATED ID: 1E1Y RELATED DB: PDB REMARK 900 LAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1FS4 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTQ RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTW RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FTY RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU4 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU7 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1FU8 RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1GFZ RELATED DB: PDB REMARK 900 FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING ATTHE REMARK 900 INHIBITOR SITE REMARK 900 RELATED ID: 1GG8 RELATED DB: PDB REMARK 900 DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE : A STUDY OFALPHA- REMARK 900 AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSECOMPOUNDS REMARK 900 RELATED ID: 1GGN RELATED DB: PDB REMARK 900 STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXESAND THE REMARK 900 IMPLICATIONS FOR STRUCTURE- BASED DRUG DESIGN REMARK 900 RELATED ID: 1GPA RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE A (R STATE) REMARK 900 RELATED ID: 1GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) REMARK 900 RELATED ID: 1GPY RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-6- REMARK 900 PHOSPHATE REMARK 900 RELATED ID: 1H5U RELATED DB: PDB REMARK 900 THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B REMARK 900 COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG REMARK 900 RELATED ID: 1HLF RELATED DB: PDB REMARK 900 BINDING OF GLUCOPYRANOSYLIDENE-SPIRO- THIOHYDANTOIN TOGLYCOGEN REMARK 900 PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUD REMARK 900 RELATED ID: 1K06 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDY OF 100 MM N- BENZOYL-N'-BETA-D- REMARK 900 GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1K08 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDY OF 10 MM N- BENZOYL-N'-BETA-D- REMARK 900 GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 1KTI RELATED DB: PDB REMARK 900 BINDING OF 100 MM N-ACETYL-N'-BETA-D- GLUCOPYRANOSYL UREA REMARK 900 TOGLYCOGEN PHOSPHORYLASE B : KINETIC AND CRYSTALLOGRAPHICSTUDIES REMARK 900 RELATED ID: 1LWN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE AIN REMARK 900 COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 ARESOLUTION REMARK 900 RELATED ID: 1LWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE AIN REMARK 900 COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 ARESOLUTION REMARK 900 RELATED ID: 1NOI RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T AND R STATES REMARK 900 RELATED ID: 1NOJ RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE REMARK 900 RELATED ID: 1NOK RELATED DB: PDB REMARK 900 COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE REMARK 900 NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE REMARK 900 RELATED ID: 1P29 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEXWITH REMARK 900 MALTOPENTAOSE REMARK 900 RELATED ID: 1P2B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEXWITH REMARK 900 MALTOHEPTAOSE REMARK 900 RELATED ID: 1P2D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEXWITH BETA REMARK 900 CYCLODEXTRIN REMARK 900 RELATED ID: 1P2G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEXWITH GAMMA REMARK 900 CYCLODEXTRIN REMARK 900 RELATED ID: 1PYG RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (PYRIDOXAL-5'- PYROPHOSPHORYL DERIVATIVE) REMARK 900 COMPLEX WITH ADENOSINE MONOPHOSPHATE REMARK 900 RELATED ID: 2AMV RELATED DB: PDB REMARK 900 THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN ALKYL- REMARK 900 DIHYDROPYRIDINE-DICARBOXYLIC ACID REMARK 900 RELATED ID: 2GPA RELATED DB: PDB REMARK 900 ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG REMARK 900 RELATED ID: 2GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE REMARK 900 RELATED ID: 2GPN RELATED DB: PDB REMARK 900 100 K STRUCTURE OF GLYCOGEN PHOSPHORYLASE AT 2.0 ANGSTROMS REMARK 900 RESOLUTION REMARK 900 RELATED ID: 2PRI RELATED DB: PDB REMARK 900 BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 2PRJ RELATED DB: PDB REMARK 900 BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B REMARK 900 RELATED ID: 2SKC RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH FLUOROPHOSPHATE, GLUCOSE REMARK 900 AND INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 2SKD RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHATE, GLUCOSE AND REMARK 900 INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 2SKE RELATED DB: PDB REMARK 900 PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHITE, GLUCOSE AND REMARK 900 INOSINE-5'- MONOPHOSPHATE REMARK 900 RELATED ID: 3AMV RELATED DB: PDB REMARK 900 ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL REMARK 900 ANTIDIABETIC DRUG REMARK 900 RELATED ID: 3GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-1- REMARK 900 PHOSPHATE REMARK 900 RELATED ID: 4GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH 2-FLUORO-2-DEOXY- REMARK 900 ALPHA-D-GLUCOSE-1 -PHOSPHATE REMARK 900 RELATED ID: 5GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH ALPHA-D-GLUCOSE-1- REMARK 900 METHYLENE-PHOSPHATE AND MALTOHEXAOSE REMARK 900 RELATED ID: 6GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH HEPTULOSE 2- REMARK 900 PHOSPHATE AND MALTOHEPTAOSE AND AMP REMARK 900 RELATED ID: 7GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (R STATE) COMPLEX WITH AMP REMARK 900 RELATED ID: 8GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (T STATE) COMPLEX WITH AMP REMARK 900 RELATED ID: 9GPB RELATED DB: PDB REMARK 900 GLYCOGEN PHOSPHORYLASE B (R STATE) DBREF 1UZU A 1 842 UNP P00489 PHS2_RABIT 1 842 SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET PLP A 999 15 HET INR A1000 48 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM INR 2',3-DIOXO-1,1',2',3-TETRAHYDRO-2,3'-BIINDOLE-5'- HETNAM 2 INR SULFONIC ACID HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN INR INDIRUBIN-5-SULPHONATE FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 INR C16 H10 N2 O5 S FORMUL 4 HOH *283(H2 O) HELIX 1 1 ILE A 13 GLY A 17 5 5 HELIX 2 2 GLY A 20 THR A 38 1 19 HELIX 3 3 THR A 47 ASP A 78 1 32 HELIX 4 4 THR A 94 ALA A 103 1 10 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 124 1 7 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 THR A 197 5 4 HELIX 9 9 GLY A 261 ASP A 268 1 8 HELIX 10 10 ALA A 272 ARG A 277 5 6 HELIX 11 11 LYS A 289 SER A 314 1 26 HELIX 12 12 ASN A 325 ASP A 327 5 3 HELIX 13 13 ALA A 328 LYS A 332 1 5 HELIX 14 14 LEU A 344 LEU A 356 1 13 HELIX 15 15 ASP A 360 THR A 371 1 12 HELIX 16 16 LEU A 380 LEU A 384 5 5 HELIX 17 17 VAL A 389 LEU A 396 1 8 HELIX 18 18 LEU A 396 PHE A 418 1 23 HELIX 19 19 ASP A 421 SER A 429 1 9 HELIX 20 20 MET A 441 GLY A 448 1 8 HELIX 21 21 ALA A 456 THR A 466 1 11 HELIX 22 22 PHE A 468 GLU A 475 1 8 HELIX 23 23 GLN A 12 CYS A 495 1 467 HELIX 24 24 ASN A 496 GLY A 508 1 13 HELIX 25 25 GLU A 509 ASP A 514 5 6 HELIX 26 26 ASP A 514 VAL A 525 5 12 HELIX 27 27 ASP A 527 GLU A 552 1 26 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ALA A 660 1 12 HELIX 31 31 THR A 676 ASN A 684 1 9 HELIX 32 32 ALA A 695 GLY A 704 1 10 HELIX 33 33 GLU A 705 PHE A 708 5 4 HELIX 34 34 ARG A 714 GLY A 725 1 12 HELIX 35 35 ASN A 727 ILE A 735 1 9 HELIX 36 36 ILE A 735 SER A 747 1 13 HELIX 37 37 PHE A 758 HIS A 768 1 11 HELIX 38 38 LYS A 772 LYS A 792 1 21 HELIX 39 39 ASN A 793 THR A 807 1 15 HELIX 40 40 SER A 808 PHE A 811 5 4 HELIX 41 41 SER A 812 ILE A 824 1 13 SHEET 1 AA 3 LYS A 191 ALA A 192 0 SHEET 2 AA 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 AA 3 LEU A 198 PHE A 202 -1 O LEU A 198 N ALA A 223 SHEET 1 AB 9 LYS A 191 ALA A 192 0 SHEET 2 AB 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 AB 9 VAL A 238 LYS A 247 -1 O ASN A 239 N VAL A 230 SHEET 4 AB 9 ALA A 154 ILE A 159 1 O ALA A 154 N THR A 240 SHEET 5 AB 9 ARG A 81 LEU A 85 1 O ILE A 82 N TYR A 155 SHEET 6 AB 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 AB 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 AB 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 AB 9 PHE A 479 ASN A 481 1 O GLN A 480 N GLY A 454 SHEET 1 AC 2 PHE A 89 GLY A 92 0 SHEET 2 AC 2 ALA A 129 LEU A 131 -1 O ALA A 129 N GLY A 92 SHEET 1 AD 2 ASN A 167 CYS A 171 0 SHEET 2 AD 2 TRP A 174 GLU A 178 -1 O TRP A 174 N CYS A 171 SHEET 1 AE 2 ARG A 205 THR A 209 0 SHEET 2 AE 2 GLY A 212 VAL A 216 -1 O GLY A 212 N THR A 209 SHEET 1 AF 3 ARG A 386 PRO A 388 0 SHEET 2 AF 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 AF 3 VAL A 431 GLU A 432 -1 O GLU A 432 N ARG A 438 SHEET 1 AG 6 LEU A 640 LEU A 645 0 SHEET 2 AG 6 ARG A 601 GLY A 606 1 O ARG A 601 N ARG A 641 SHEET 3 AG 6 LEU A 562 VAL A 567 1 O LEU A 562 N THR A 602 SHEET 4 AG 6 LEU A 662 GLN A 665 1 O LEU A 662 N VAL A 565 SHEET 5 AG 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 AG 6 PHE A 709 ILE A 710 1 O PHE A 709 N GLY A 690 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.35 SITE 1 AC1 15 LYS A 568 LYS A 574 TYR A 648 ARG A 649 SITE 2 AC1 15 VAL A 650 GLY A 675 THR A 676 GLY A 677 SITE 3 AC1 15 LYS A 680 HOH A2183 HOH A2277 HOH A2278 SITE 4 AC1 15 HOH A2279 HOH A2280 HOH A2281 SITE 1 AC2 6 ASN A 282 PHE A 285 ALA A 610 GLY A 612 SITE 2 AC2 6 TYR A 613 HOH A2282 CRYST1 128.652 128.652 116.389 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007773 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007773 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008592 0.00000